Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 53.36

+3.4%

10:31 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: IRWIN JAMES FRANKEL who wrote (1721)	9/22/2000 8:24:42 AM
From: Biomaven	Read Replies (2) of 52153

ij, negative cash flow of $1.5 million per quarter No, this is way too high. Looks to me like this is may be a reasonable figure for three quarters. There was a loss from operations of $.5 million for the last quarter, and of $1.5 million for the three quarters. To some extent this is a "razor/razorblade" operation, so once they grow some their numbers should start looking much better. Looks like there are still a bunch of sellers around - maybe some of the early VC guys are still bailing. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next